Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

EHA 2011

9 - 12 Jun 2011

Auckland, New Zealand

Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life

Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston

Ruxolitinib successfully treats myelofibrosis symptoms and improves quality of life ( Dr Srdan Verstovsek - The University of Texas, MD Anderson Cancer Centre, Houston )

Patient non-compliance to treatment schedules

Giora Sharf - Israeli CML Patient's Support Group

Patient non-compliance to treatment schedules ( Giora Sharf - Israeli CML Patient's Support Group )

VTD consolidation therapy for multiple myeloma

Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy

VTD consolidation therapy for multiple myeloma ( Professor Michele Cavo - Institute of Haematology & Medical Oncology Seragnoli, University of Bologna, Italy )

Dasatinib therapy for CML patients unsuitable for imatinib

Prof Giuseppe Saglio - University of Turin, Italy

Dasatinib therapy for CML patients unsuitable for imatinib ( Prof Giuseppe Saglio - University of Turin, Italy )

Key CLL research from EHA 2011

Prof Emili Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain

Key CLL research from EHA 2011 ( Prof Emili Montserrat - Institute of Haematology and Oncology, Hospital Clinic, Spain )

Patient advocacy session on treatment adherence

Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK

Patient advocacy session on treatment adherence ( Jan Geissler - Co-founder, CML Advocates Network; Giora Sharf - Israeli CML Patient’s Support Group; Dr Lina Eliasson - Imperial College London, UK )

Latest advances in multiple myeloma

Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands

Latest advances in multiple myeloma ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )

Advances in CLL treatment

Prof Peter Hillmen - St James’s University Hospital, Leeds, UK

Advances in CLL treatment ( Prof Peter Hillmen - St James’s University Hospital, Leeds, UK )

TKI treatment for chronic myeloid leukaemia

Dr Hagop Kantarjian - MD Anderson Cancer Center, Texas, USA

TKI treatment for chronic myeloid leukaemia ( Dr Hagop Kantarjian - MD Anderson Cancer Center, Texas, USA )

Communicating end of life options

Dr Steve Johnson – Yeovil District Hospital, UK & Prof Anton Hagenbeek - Academic Medical Centre, Amsterdam, Netherlands

Communicating end of life options ( Dr Steve Johnson – Yeovil District Hospital, UK & Prof Anton Hagenbeek - Academic Medical Centre, Amsterdam, Netherlands )

Advances in the treatment of multiple myeloma

Prof Mario Boccadoro - San Giovanni Hospital, Turin, Italy

Advances in the treatment of multiple myeloma ( Prof Mario Boccadoro - San Giovanni Hospital, Turin, Italy )

Second generation TKIs in chronic myeloid leukaemia

Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia

Second generation TKIs in chronic myeloid leukaemia ( Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia )

Auto transplants, 1st, 2nd & 3rd generation novel agents improve outlook in multiple myeloma

Prof Jesús San Miguel - University Hospital of Salamanca, Spain

Auto transplants, 1st, 2nd & 3rd generation novel agents improve outlook in multiple myeloma ( Prof Jesús San Miguel - University Hospital of Salamanca, Spain )

Role of maintenance therapy in multiple myeloma

Prof Gareth Morgan, Prof Antonio Palumbo and Dr Paul Richardson

Role of maintenance therapy in multiple myeloma ( Prof Gareth Morgan, Prof Antonio Palumbo and Dr Paul Richardson )

Philadelphia chromosome targeting; mantle cell lymphoma maintenance; double cord transplants; funding for haematology

Prof Robin Foà - Sapienza University of Rome, Italy

Philadelphia chromosome targeting; mantle cell lymphoma maintenance; double cord transplants; funding for haematology ( Prof Robin Foà - Sapienza University of Rome, Italy )

Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy

Dr Paul Richardson - Dana Farber Institute, Boston, USA

Multiple Myeloma: New Rescue Options For Patients After Front-Line Therapy ( Dr Paul Richardson - Dana Farber Institute, Boston, USA )

More from ecancer